Please sign in to follow a disease.

Lymphocyte B CD22 positive acute lymphoblastic leukemia

Clinical trials for Lymphocyte B CD22 positive acute lymphoblastic leukemia explained in plain language.

Never miss a new study

Get alerted when new Lymphocyte B CD22 positive acute lymphoblastic leukemia trials appear

Sign up with your email to follow new studies for Lymphocyte B CD22 positive acute lymphoblastic leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Leukemia trial pulled before it started: safer transplant prep remains untested

Disease control Cancelled

This trial was designed to test a milder conditioning regimen using a radioactive antibody (90Y-Epratuzumab) followed by chemotherapy and a stem cell transplant for adults with CD22-positive B-cell acute lymphoblastic leukemia. The goal was to find the safest dose that still cont…

Matched conditions: LYMPHOCYTE B CD22 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

Phase 1/2 • Sponsor: Nantes University Hospital • Aim: Disease control

Last updated Jun 27, 2026 14:03 UTC

Lymphocyte B CD22 positive acute lymphoblastic leukemia

Get alerted when new Lymphocyte B CD22 positive acute lymphoblastic leukemia trials appear

Leukemia trial pulled before it started: safer transplant prep remains untested